OpenScience.ink

3 weeks ago • Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Lower risks of falls and hip fractures with semaglutide and tirzepatide compared to DPP-4 inhibitors in older adults with type 2 diabetesLower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes.

🎖️ Top 10% Journal

3 weeks ago • The oncologist

Use of GLP-1 receptor drugs and survival in women with type 2 diabetes and breast cancerGLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study.

🥉 Top 5% Journal

3 weeks ago • Pharmacoepidemiology and drug safety

Use of Negative Controls in Real-World Studies of Diabetes Drugs Acting on GLP-1 ReceptorsHow Negative Controls Are Used in Pharmacoepidemiology: A Methodological Scoping Review of Real-World Observational Studies of Glucagon-Like Peptide-1 Receptor Agonists.

3 weeks ago • BMC cardiovascular disorders

Tirzepatide and the risk of new aortic valve narrowing in people with obesityTirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort study.

📖 Top 30% Journal

3 weeks ago • Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

How Non-Experts Influence Online Conversations About Mounjaro on Twitter (X)Influence without medical expertise: a social network analysis of Mounjaro discussions on twitter (X).

📖 Top 30% Journal

3 weeks ago • The Medical journal of Australia

Weight Loss Drug Marketing and First Nations People: Focus on Health Awareness or Company Profit?Weight Loss Medication Marketing and First Nations People: Disease Awareness or Corporate Profit?

🎖️ Top 10% Journal

3 weeks ago • American journal of cardiovascular drugs : drugs, devices, and other interventions

Combined Treatment with GLP-1 Receptor Agonists and SGLT2 Inhibitors in Patients with Heart Failure: Review and Analysis of Observational StudiesCombination Therapy of GLP-1 RA and SGLT2i in Patients with Established Heart Failure: A Systematic Review and Meta-Analysis of Observational Studies.

📖 Top 20% Journal

3 weeks ago • NPJ cardiovascular health

Semaglutide's heart benefits relate more to the dose taken than to the amount of weight lostSemaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss.

3 weeks ago • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Effects of Glucagon-like Peptide-1 Drugs in Parkinson's Disease: A Meta-AnalysisGlucagon-like peptide-1 agonists in Parkinson's disease: a meta-analysis.

📖 Top 30% Journal

3 weeks ago • BMC ophthalmology

Partially reversible sudden vision loss in both eyes and blocked small retinal artery after semaglutide use: a case reportPartially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report.

📖 Top 30% Journal

3 weeks ago • Handbook of experimental pharmacology

TAAR1 as a possible new target instead of GLP-1 for diabetes and obesity drugsTAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications.

📖 Top 20% Journal

3 weeks ago • Case reports in gastroenterology

Blocking a Specific Intestinal Bile Acid Transporter to Treat Severe Constipation Caused by Tirzepatide: A Case ReportTargeted Ileal Bile Acid Transporter Inhibition as Rescue Therapy for Tirzepatide-Induced Severe Constipation: A Case Report.

3 weeks ago • Alcohol, clinical & experimental research

Links Between Prescriptions of a Diabetes Drug and Alcohol Drinking in a Large U.S. Health StudyAssociation of GLP-1 Receptor Agonist Prescriptions and Alcohol Consumption in the National Institutes of Health's All of Us Cohort.

📖 Top 20% Journal

3 weeks ago • Diabetes & vascular disease research

Tirzepatide compared to DPP-4 inhibitors for type 2 diabetes in people with heart failureComparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure.

3 weeks ago • Frontiers in endocrinology

How fat location affects metabolism: biology, health measures, and treatment approachesAdipose tissue distribution in metabolic disease: depot-specific biology, clinical assessment, and therapeutic remodeling.

🎖️ Top 10% Journal

3 weeks ago • Diabetes, obesity & metabolism

How SGLT2 Inhibitors and GLP-1 Receptor Agonists May Affect Heart Rhythm Problems and Heart Events in Different DiseasesEfficacy and Safety of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Ventricular Arrhythmias and Cardiovascular Events: A Disease-Stratified Network Meta-Analysis.

3 weeks ago • The International journal of eating disorders

Activating GLP-1 Receptors Increases Activity-Based Anorexia in MiceGLP-1 Receptor Agonism Exacerbates Activity-Based Anorexia in Mice.

3 weeks ago • Journal of translational medicine

Breaking the cycle between unhealthy fat tissue and inflammation: a new approach to inflammatory diseaseDisrupting the adiposopathy-inflammation loop: a translational immunometabolic framework for inflammatory disease.

🥉 Top 5% Journal

3 weeks ago • Peptides

Glicentin as a weak activator of the glucose-dependent insulin-stimulating receptorIdentification of glicentin as a low-potency glucose-dependent insulinotropic polypeptide receptor agonist.

3 weeks ago • Otolaryngologic clinics of North America

How Obesity and Weight Loss Relate to Nose and Allergy HealthObesity, Weight Loss, and Rhinology and Allergy.

📖 Top 50% Journal

← prevpage 12 of 15next →

Latest GLP-1 Therapies Research Papers